Regulatory News

Read the latest regulatory and product updates from Par Health.

October 13, 2026

Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter

October 8, 2026

Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter

September 18, 2026

Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter

Corporate News

Read the latest news releases and announcements from Par Health.

View Corporate News

View News Archive

Media Contact

For questions or comments, reach our Media Relations team here.

First Name

Last Name

Email Address

Media Outlet/Organization

Comment

Smallprint

This form is not intended for reporting adverse drug experiences. To report an adverse event, please visit our Contact Us page for the appropriate channels.